Director Shareholding
Deltex Medical Group PLC
07 May 2003
Deltex Medical Group plc ('Deltex Medical' or the 'Company')
Director Shareholdings
Deltex Medical announced yesterday that it has completed its fundraising of
approximately £1.32 million before expenses, involving the subscription of
18,858,499 new ordinary shares at 7p per share by various institutional and
other investors and the Directors.
As previously announced on 1 April 2003, in order to demonstrate their
confidence in the Group's prospects, the Directors have participated as
investors in the fundraising, subscribing approximately £0.36 million. Their
interests in the Company's total issued ordinary share capital following
completion of the fundraising are as follows:
Following the fundraising
Name of Director Amount Number of Holding of % of issued
subscribed subscription shares share capital
shares
£
Nigel Keen 150,000 2,142,857 2,862,544 5.10
Nigel Keen (1) - - 589,700 1.05
Andy Hill 3,000 42,857 42,857 0.08
Ewan Phillips 20,000 285,714 365,714 0.65
Daniel Bretonneau 10,000 142,857 142,857 0.25
Edwin Snape (2) 160,000 2,285,714 2,879,925 5.13
Kempton Coady 1,260 18,000 58,000 0.10
George Flouty 4,500 64,285 134,285 0.24
Peter Smedvig (3) 13,020 186,000 664,478 1.18
------------ ------------ ------------ ------------
361,780 5,168,284 7,740,360 13.78
------------ ------------ ------------ ------------
(1) as trustee and executor of the Pauline Thomas Charity Will
Trust
(2) as principal of NEGF II L.P. and New England Partners Capital
L.P.
(3) as director of Peder Smedvig Capital AS
7 May 2003
This information is provided by RNS
The company news service from the London Stock Exchange